Actimus Bio
Visakhapatnam, India· Est.
Actimus Bio provides end‑to‑end CRO services to accelerate drug development for global pharma and biotech sponsors.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Actimus Bio provides end‑to‑end CRO services to accelerate drug development for global pharma and biotech sponsors.
Technology Platform
State‑of‑the‑art analytical labs, FDA‑approved facilities, and integrated data management platforms enable high‑quality bioanalytical, PK/PD, and statistical services.
Opportunities
Rising demand for outsourced clinical and analytical services in emerging markets and increasing complexity of regulatory requirements.
Risk Factors
Intense competition from global CROs and reliance on regulatory approvals of its facilities.
Competitive Landscape
Competes with Indian CROs such as Syngene, GVK Biosciences, and international players like IQVIA, differentiating through FDA‑approved labs and an integrated service portfolio.